11.25 USD
↘ 0.24 (2.09%)PRE MARKET (AS OF 07:59 AM EST)
AbCellera Biologics Inc. Common Shares (ABCL) trades at $11.25 per share. Technicals currently rate "Sell" while our fundamental analysis reads "Neutral". Notable factors include a robust Altman Z-Score, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Nov 13, 2026.